← DocG Medical Summaries
Top Cardiology Research Papers
1.
8.3
Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults.
Overall: This rigorous, large trial shows that atorvastatin moderately reduces major cardiovascular events in healthy older adults without extending disability-free survival, offering directly actionable evidence for US preventive care.
2.
8.2
Low-Voltage Ablation in Persistent Atrial Fibrillation: The IDEAL-AF Randomized Clinical Trial.
Overall: This randomized multicenter trial found a large improvement in arrhythmia-free survival and quality of life without greater serious harm, supporting a potentially practice-changing but specialized ablation strategy.
3.
8.2
Complete Revascularization Guided by Functional Coronary Angiography in STEMI.
Overall: A large randomized trial found that physiology-guided complete revascularization produced a meaningful reduction in clinical events and fewer major safety events than conventional angiographic guidance.
4.
8.1
Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.
Overall: A large, precise randomized-trial meta-analysis supports blood-pressure lowering to prevent major cardiovascular events throughout CKD, but absent absolute effects and harms limit conclusions about net benefit.
5.
8.1
Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.
Overall: This randomized trial provides clinically meaningful evidence that stable patients without heart failure or substantial systolic dysfunction may discontinue beta-blockers after the first post-infarction year without worse major clinical outcomes.
6.
8.0
Stroke and Bleeding Risks With Non-Vitamin K Oral Anticoagulants in Nonvalvular Atrial Fibrillation.
Overall: This large, directly applicable US cohort supports apixaban as having the most favorable comparative benefit-harm profile in younger adults with atrial fibrillation, but residual confounding and absent absolute event rates temper confidence.
7.
7.9
Tricuspid-Valve Intervention in Heart Failure.
Overall: This randomized trial reports a large, precise improvement in major patient outcomes, balanced against procedural adverse events and the need for specialized structural-heart resources.
8.
7.7
A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.
Overall: A large and precise randomized-trial meta-analysis demonstrates early, modest reductions in major cardiovascular events from blood-pressure lowering, with high primary-care relevance but limited novelty and no reported harms.
9.
7.6
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.
Overall: A large randomized trial analysis shows clinically meaningful reductions in first and recurrent cardiovascular events, though absent safety reporting and the practical burdens of evolocumab temper the net impact.
10.
7.6
Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease.
Overall: This well-conducted randomized trial found a clinically meaningful reduction in repeat limb procedures or major amputation without an evident one-year safety penalty, supporting potential adoption during infrainguinal angioplasty.
Score Guide:
9-10 Exceptional
7-8 Strong
5-6 Moderate
3-4 Weak
1-2 Poor
Top papers in other specialties
Emergency MedicineFamily Medicine / General Practice / Primary CareHospital MedicineInternal MedicineAllergy & ImmunologyDermatologyEndocrinologyGastroenterologyGeneticsGeriatricsHematologyInfectious DiseaseTropical & Travel MedicineCritical CareNephrologyNeurologyObesityOccupational & Environmental HealthOncologyPain MedicinePalliative & Supportive CarePhysical Medicine & RehabilitationPsychiatryPublic HealthPulmonology/RespirologyRheumatologyGynecologyObstetricsPediatrics (General)Pediatric Hospital MedicineNeonatologyPediatric Emergency MedicineAnesthesiologyOphthalmologyOtolaryngology (ENT)OrthopedicsUrologySurgery (Other)Sports MedicineAddiction Medicine